NVIV - InVivo Therapeutics Holdings Corp.

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
1.35
-0.15 (-10.00%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close1.50
Open1.50
Bid1.20 x 2500
Ask1.40 x 900
Day's Range1.35 - 1.50
52 Week Range1.10 - 5.90
Volume178,471
Avg. Volume313,189
Market Cap46.18M
Beta3.24
PE Ratio (TTM)-1.77
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • What Is InVivo Therapeutics Holdings Corp’s (NVIV) Share Price Doing?
    Simply Wall St.8 days ago

    What Is InVivo Therapeutics Holdings Corp’s (NVIV) Share Price Doing?

    InVivo Therapeutics Holdings Corp (NASDAQ:NVIV), a healthcare equipment and supplies company based in United States, saw a significant share price rise of over 20% in the past couple of monthsRead More...

  • Associated Press2 months ago

    InVivo reports 2Q loss

    The Cambridge, Massachusetts-based company said it had a loss of 20 cents per share. The company's shares closed at $1.80. A year ago, they were trading at $6.36. _____ This story was generated by Automated ...

  • 24/7 Wall St.4 months ago

    Wednesday’s Biggest Early Market Movers

    The broad markets have hit new highs over the past two weeks on the back of a strong earnings season. But Tuesday was a huge step back for these major indexes.

  • Associated Press5 months ago

    InVivo reports 1Q loss

    The Cambridge, Massachusetts-based company said it had a loss of 20 cents per share. The company's shares closed at $3.40. A year ago, they were trading at $5.87. _____ This story was generated by Automated ...

  • Associated Press7 months ago

    InVivo reports 4Q loss

    The Cambridge, Massachusetts-based company said it had a loss of 17 cents per share. Losses, adjusted for non-recurring gains, came to 21 cents per share. For the year, the company reported a loss of $23.4 ...

  • Investopedia9 months ago

    InVivo Gains on Neuro-Spinal Scaffold Results

    InVivo said interim results suggest its Neuro-Spinal Scaffold can help treat spinal cord injury.

  • Zacks9 months ago

    Here's Why InVivo Therapeutics is Gaining Today

    On Tuesday, shares of medical device company InVivo Therapeutics (NVIV) are gaining big, up almost 15% in afternoon trading on news that a patient in its INSPIRE study has significantly improved.

  • Investopedia9 months ago

    PixarBio Offers to Acquire InVivo for $77 Million

    PixarBio offered to acquire Invivo Therapeutics for $77 million in stock.

  • Invivo Therapeutics Holdings Corp. :NVIV-US: Earnings Analysis: Q3, 2016 By the Numbers : November 29, 2016
    Capital Cube11 months ago

    Invivo Therapeutics Holdings Corp. :NVIV-US: Earnings Analysis: Q3, 2016 By the Numbers : November 29, 2016

    Categories: Yahoo Finance Get free summary analysis Invivo Therapeutics Holdings Corp. reports financial results for the quarter ended September 30, 2016. Analysis Summary numbers: Revenues of USD 0 million, Net Earnings of USD -6.20 million. The company did not record any revenues for the last twelve months making the comparison of net margin versus asset turnover meaningless. NVIV-US‘s ... Read more (Read more...)